1 Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group GMMG, Heidelberg University Hospital and Medical Faculty Heidelberg, Germany
2 Division of Biostatistics, German Cancer Research Center
3 National Center for Tumor Diseases Heidelberg, Germany
4 Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Germany
5 Department of Internal Medicine II, University Hospital Tübingen, Germany
6 Department for Hematology and Stem Cell Transplantation, University Hospital Essen, Germany
7 Department of Hematology and Oncology, Knappschaft Kliniken, Ruhr-University Bochum, Germany
8 Department of Medicine II-Hematology and Oncology, Goethe-University Frankfurt, University Hospital, Frankfurt am Main, Germany
9 Department of Internal Medicine III, Klinikum Chemnitz, Germany
10 Department for Hematology, Oncology and Immunology, University Hospital Giessen and Marburg, Marburg, Germany
11 Department of Oncology, Hematology and BMT, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
12 Clinic for Oncology and Hematology, Hospital Barmherzige Brueder Regensburg, Germany
13 Department of Internal Medicine I, University Hospital Cologne, Germany
14 The Binding Site GmbH, part of Thermo Fisher Scientific, Schwetzingen, Germany
15 Medical Clinic, Charité University Medicine Berlin, Germany
16 Coordination Centre for Clinical Trials-KKS, University Hospital and Medical Faculty Heidelberg, Germany
17 Department of Hematology, Oncology, Stem Cell Transplantation, Immune and Cell Therapy, Clinical Immunology and Rheumatology, University Hospital Bonn, Germany
18 Department of Internal Medicine I, University Hospital Dresden, Germany
19 Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Germany
20 Clinic for Hematology, Oncology and Palliative Care, Marien Hospital Düsseldorf, Germany
21 Clinic for Hematology, Oncology and Immunology, Klinikum Siloah Hannover, Germany
22 Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Germany
23 Center for Hematology and Oncology Bethanien, Frankfurt am Main, Germany
24 Department of Internal Medicine III, University Hospital Mainz, Germany
25 Department of Internal Medicine III, Diakoneo Clinic Schwäbisch-Hall, Schwäbisch-Hall, Germany
26 Hematology/Oncology Center, Bielefeld, Germany
27 Hematology/Oncology Center, Koblenz, Germany
28 Medical Clinic A, Clinic Ludwigshafen, Germany
29 MVZ Labor Dr. Limbach und Kollegen, Heidelberg, Germany
30 Asklepios Tumorzentrum Hamburg, AK Altona and AK St Georg, Germany. °For The German-Speaking Myeloma Multicenter Group. *Contributed equally as senior authors. *Hd7 Investigators
